Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Treatment of Recurrent Glioblastoma by Chronic Convection-Enhanced Delivery of Topotecan

medRxiv(2021)10.1101/2021.12.04.21266935Source: DataRank Database

Treatment of Recurrent Glioblastoma by Chronic Convection-Enhanced Delivery of Topotecan is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.227. It has been cited 3 times, with 2 citing works in its 1-hop citation network.

N/A

0.227DataRank · unranked

Scored on demand from live citation data

Open Access3 citations · 2 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (24)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 92%Citation Network 8%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

0.0187

From 2 citing papers with measurable signal

Learn more about DataRank methodology →

Top 2 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 2 citers.

Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma
Cancers202228 citations271 referencesContributes 0.012
Advancing glioblastoma therapy: Learning from the past and innovations for the future
Cancer Letters202517 citations301 referencesContributes 0.010

Authors (34)

Michael Argenziano ORCID,Pavan S. Upadhyayula ORCID,Matei A. Banu ORCID,Justin A. Neira,Dominique Higgins ORCID

Live enrichment

PubMed:30945415 OpenAlex:https://openalex.org/W4200621939

National Institutes of Health

Grant: 5R01CA161404-06

CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA

National Institutes of Health

Grant: 5R01NS103473-05

Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence

National Institutes of Health

Grant: 3UL1TR001873-07S1

Clinical and Translational Science Award

National Institutes of Health

Grant: 5P30CA013696-43

Cancer Center Support Grant

National Institutes of Health

Grant: 5UG1CA189960-04

Columbia University Minority/Underserved Site NCI Community Oncology Research Program

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/12/06/2021.12.04.21266935.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.12.04.21266935

repositoryhttps://doi.org/10.1101/2021.12.04.21266935

Fields of Study

Glioma Diagnosis and TreatmentNanoplatforms for cancer theranosticsExtracellular vesicles in disease03 medical and health sciences0302 clinical medicine

Keywords

TopotecanMedicineDrug deliveryGlioblastomaGliomaBrain tumorChemotherapyMalignancyDrugTumor progressionRefractory (planetary science)OncologyCancer researchPathologyPharmacologyInternal medicineCancerChemistryBiology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being